News Focus
News Focus
Followers 5
Posts 5220
Boards Moderated 1
Alias Born 03/21/2024

Re: improving post# 754540

Monday, 03/17/2025 10:00:46 AM

Monday, March 17, 2025 10:00:46 AM

Post# of 824230
Right, that’s why they continue to lie about their US and FDA pathway. UK approval wont change much in terms of attractiveness towards generating free cash flow, but continue to pump. They have mislead shareholders around other regulatory applications as well as reimbursements in the UK.

They will get slapped with a lawsuit later this year. There is no hiding. Some of the shareholders that care about highest level of business ethics, execution, and importantly ROI will not tolerate this anymore. They (management) have been given enough leeway and benefit of doubt over the last decade or so.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News